145 related articles for article (PubMed ID: 4320691)
1. Haemodynamic changes in women taking oral contraceptives.
Walters WA; Lim YL
J Obstet Gynaecol Br Commonw; 1970 Nov; 77(11):1007-12. PubMed ID: 4320691
[No Abstract] [Full Text] [Related]
2. Haemodynamic effects of combined oestrogen-progestogen oral contraceptives.
Lehtovirta P
J Obstet Gynaecol Br Commonw; 1974 Jul; 81(7):517-25. PubMed ID: 4846176
[No Abstract] [Full Text] [Related]
3. Cardiovascular dynamics in women receiving oral contraceptive therapy.
Walters WA; Lim YL
Lancet; 1969 Oct; 2(7626):879-81. PubMed ID: 4186458
[No Abstract] [Full Text] [Related]
4. Malignant hypertension with irreversible renal failure due to oral contraceptives.
Zech P; Rifle G; Lindner A; Sassard J; Blanc-Brunat N; Traeger J
Br Med J; 1975 Nov; 4(5992):326-7. PubMed ID: 1192051
[TBL] [Abstract][Full Text] [Related]
5. Changes in blood coagulation and fibrinolysis in women receiving oral contraceptives. Comparison between treated and untreated women in a longitudinal study.
Ygge J; Brody S; Korsan-Bengtsen K; Nilsson L
Am J Obstet Gynecol; 1969 May; 104(1):87-98. PubMed ID: 4180662
[TBL] [Abstract][Full Text] [Related]
6. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
Gidwani GP; Purandare BN
J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
[TBL] [Abstract][Full Text] [Related]
7. Effect of ethynodiol diacetate and a combination-type oral contraceptive compound on carbohydrate metabolism. II. One year intravenous glucose tolerance study.
Goldman JA
Diabetologia; 1977 Apr; 13(2):89-91. PubMed ID: 856654
[TBL] [Abstract][Full Text] [Related]
8. Steroid contraceptives: neuro-psychiatric & electroencephalographic complications.
Elwan O; Madkour O; Kamal I; Abdallah M
J Int Med Res; 1973; 1(6):534-47. PubMed ID: 4806735
[TBL] [Abstract][Full Text] [Related]
9. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
Kamal I; Hefnawi F; Younis N
Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
[TBL] [Abstract][Full Text] [Related]
10. [A case of arterial hypertension imputable to an estroprogestational contraceptive. Implication of the renin-angiotensin-aldosterone system].
Fontenaille C; Camelot G; Béquart P; Boulangé M
J Urol Nephrol (Paris); 1969 Dec; 75(12):950-5. PubMed ID: 4314141
[TBL] [Abstract][Full Text] [Related]
11. Haemodynamic effects of low doses of female sex steroids.
Walters WA; Cain D
Aust N Z J Obstet Gynaecol; 1973 Nov; 13(4):213-8. PubMed ID: 4615701
[No Abstract] [Full Text] [Related]
12. [Thrombelastography and oral contraceptives].
Delacrétaz-Dubugnon F
Schweiz Med Wochenschr; 1972 Jan; 102(2):48-52. PubMed ID: 4644685
[No Abstract] [Full Text] [Related]
13. Cerebral ischaemic lesions and oral contraception.
Kjaer M; De Fine Olivarius B; Waarst A
Dan Med Bull; 1971 Dec; 18(6):129-37. PubMed ID: 5136191
[No Abstract] [Full Text] [Related]
14. Amenorrhoea following oral contraception.
Starup J
Acta Obstet Gynecol Scand; 1972; 51(4):341-5. PubMed ID: 4642722
[No Abstract] [Full Text] [Related]
15. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
[TBL] [Abstract][Full Text] [Related]
16. Oral contraception and elevated blood pressure.
Tyson JE
Am J Obstet Gynecol; 1968 Mar; 100(6):875-7. PubMed ID: 5642586
[No Abstract] [Full Text] [Related]
17. A study of blood coagulation parameters.
Newman RL; Sirridge M; Brinkman M; Shannon R
Am J Obstet Gynecol; 1976 May; 125(1):108-14. PubMed ID: 775991
[TBL] [Abstract][Full Text] [Related]
18. Liver hamartomas in patients on oral contraceptives.
O'Sullivan JP; Wilding RP
Br Med J; 1974 Jul; 3(5922):7-10. PubMed ID: 4835461
[TBL] [Abstract][Full Text] [Related]
19. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Wilson ES; Cruickshank J; McMaster M; Weir RJ
Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
[TBL] [Abstract][Full Text] [Related]
20. Effects of steroidal antifertility agents after two to six years of continuous use.
Rice-Wray E; Cervantes A; Gastelum H
Int J Fertil; 1967; 12(3):312-9. PubMed ID: 4166548
[No Abstract] [Full Text] [Related]
[Next] [New Search]
